Taiki Matsubayashi, Kotaro Yoshioka, Su Su Lei Mon, Maho Katsuyama, Chunyan Jia, Takao Yamaguchi, Rintaro Iwata Hara, Tetsuya Nagata, Osamu Nakagawa, Satoshi Obika, Takanori Yokota. Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2′,4′-BNA/LNA with 9-(aminoethoxy)phenoxazine Mol Ther Nucleic Acids. 2024.03;

Chunyan Jia, Su Su Lei Mon, Ying Yang, Maho Katsuyama, Kie Yoshida-Tanaka, Tetsuya Nagata, Kotaro Yoshioka, Takanori Yokota. Change of intracellular calcium level causes acute neurotoxicity by antisense oligonucleotides via CSF route Molecular Therapy Nucleic Acids. 2023.03;

Yohei Kawano, Maki Obana, Masashi Nagata, Yasunari Mano, Maho Katsuyama, Yuichiro Yamamoto, Ayako Maeda-Minami, Kenichi Negishi, Masamichi Takagi, Shuji Shimada, Takao Aoyama. The antiplatelet effect of mirtazapine is mediated by co-blocking 5-HT2A and α2-adrenergic receptors on platelets: An in vitro human plasma-based study Eur J Pharmacol. 2022.02; 917 174640. ( PubMed, DOI )

Yohei Kawano, Maho Katsuyama, Masashi Nagata, Maki Obana, Satoshi Nakamatsu, Ayano Mori, Namiki Sakamoto, Yasunari Mano, Kenichi Negishi, Shuji Shimada, Takao Aoyama. Antiplatelet Effect of Mirtazapine via Co-blocking of the 5-HT2A and α2-Adrenergic Receptors on Platelets Biol Pharm Bull. 2021; 44 (2): 238-244. ( PubMed, DOI )

神経・筋疾患を標的とした核酸医薬の基礎と臨床 神経治療学. 2023; 40 (3): 237-241.

Maho Katsuyama, Kotaro Yoshioka, Su Su Lei Mon, Chunyan Jia, Kie Tanaka, Rintaro Iwata Hara, Tetsuya Nagata, Takanori Yokota. Heteroduplex oligonucleotide technology that enables mitigation of neurotoxicity by antisense oligonucleotides. 19th Annual Meeting of the Oligonucleotide Therapeutics Society 2023.10.22

Maho Katsuyama, Kotaro Yoshioka, Su Su Lei Mon, Chunyan Jia, Kie Tanaka, Rintaro Iwata Hara, Tetsuya Nagata, Takanori Yokota. Development of heteroduplex oligonucleotide that enable mitigation of neurotoxicity by antisense oligonucleotides. 日本核酸医薬学会第8回年会 2023.07.11

Maho Katsuyama, Kotaro Yoshioka, Chunyan Jia, Su Su Lei Mon, Kie Tanaka, Tetsuya Nagata, Takanori Yokota. Structure- “neurotoxicity” correlation in antisense oligonucleotides targeting central nervous system. 18th Annual Meeting of the Oligonucleotide Therapeutics Society 2022.10.02

Maho Katsuyama, Kotaro Yoshioka, Chunyan Jia, Su Su Lei Mon, Ying Yang, Kie Tanaka, Tetsuya Nagata, Takanori Yokota. Elucidation of structure- “neurotoxicity” correlation in antisense oligonucleotides targeting central nervous system. 日本核酸医薬学会第7回年会 2022.07.31

Maho Katsuyama, Kotaro Yoshioka, Chunyan Jia, Su Su Lei Mon, Taiki Matsubayashi, Kie Tanaka, Tetsuya Nagata, Takanori Yokota. in vitro cytotoxicity assay of antisense oligonucleotides to predict CNS-toxicity in vivo.. NEURO2022 2022.06.30